Global Haemophilus Parasuis Bivalent Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Haemophilus Parasuis Bivalent Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Haemophilus parasuis disease, also known as Grazer's disease, is an upper respiratory infectious disease of pigs caused by Haemophilus parasuis (HPS), mainly infecting piglets before and after weaning, clinically manifested as multiple fibrosis Serositis, arthritis and meningitis. The inactivated vaccine against Haemophilus parasuis can effectively prevent Haemophilus parasuis and reduce the mortality rate of Haemophilus parasuis infection.
This report is a detailed and comprehensive analysis for global Haemophilus Parasuis Bivalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Haemophilus Parasuis Bivalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus Parasuis Bivalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus Parasuis Bivalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus Parasuis Bivalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Haemophilus Parasuis Bivalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Haemophilus Parasuis Bivalent Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer-Ingelheim, Eurovet, Hipra and Nisseiken, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Haemophilus Parasuis Bivalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Haemophilus Parasuis Bivalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Haemophilus Parasuis Bivalent Vaccine, with price, sales, revenue and global market share of Haemophilus Parasuis Bivalent Vaccine from 2018 to 2023.
Chapter 3, the Haemophilus Parasuis Bivalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Haemophilus Parasuis Bivalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Haemophilus Parasuis Bivalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Haemophilus Parasuis Bivalent Vaccine.
Chapter 14 and 15, to describe Haemophilus Parasuis Bivalent Vaccine sales channel, distributors, customers, research findings and conclusion.
Haemophilus parasuis disease, also known as Grazer's disease, is an upper respiratory infectious disease of pigs caused by Haemophilus parasuis (HPS), mainly infecting piglets before and after weaning, clinically manifested as multiple fibrosis Serositis, arthritis and meningitis. The inactivated vaccine against Haemophilus parasuis can effectively prevent Haemophilus parasuis and reduce the mortality rate of Haemophilus parasuis infection.
This report is a detailed and comprehensive analysis for global Haemophilus Parasuis Bivalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Haemophilus Parasuis Bivalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus Parasuis Bivalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus Parasuis Bivalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Haemophilus Parasuis Bivalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Haemophilus Parasuis Bivalent Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Haemophilus Parasuis Bivalent Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis, Boehringer-Ingelheim, Eurovet, Hipra and Nisseiken, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Haemophilus Parasuis Bivalent Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Bivalent Inactivated Vaccine
- Trivalent Inactivated Vaccine
- Quadrivalent Inactivated Vaccine
- Piglets
- Adults Pigs
- Zoetis
- Boehringer-Ingelheim
- Eurovet
- Hipra
- Nisseiken
- Merck Animal Health
- SPAH
- Pulike Biological Engineering
- China Animal Husbandry Industry
- Wuhan Keqian Biology
- Wo Hua Biotech
- Zhejiang Ceva Ebvac Biotech
- Luoyang Huizhong Biotech
- Beijing Centrebio Biology
- Shandong Huahong Bioengineering
- Ringpu
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Haemophilus Parasuis Bivalent Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Haemophilus Parasuis Bivalent Vaccine, with price, sales, revenue and global market share of Haemophilus Parasuis Bivalent Vaccine from 2018 to 2023.
Chapter 3, the Haemophilus Parasuis Bivalent Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Haemophilus Parasuis Bivalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Haemophilus Parasuis Bivalent Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Haemophilus Parasuis Bivalent Vaccine.
Chapter 14 and 15, to describe Haemophilus Parasuis Bivalent Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Haemophilus Parasuis Bivalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Bivalent Inactivated Vaccine
1.3.3 Trivalent Inactivated Vaccine
1.3.4 Quadrivalent Inactivated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Haemophilus Parasuis Bivalent Vaccine Market Size & Forecast
1.5.1 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
2.1.4 Zoetis Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 Eurovet
2.3.1 Eurovet Details
2.3.2 Eurovet Major Business
2.3.3 Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
2.3.4 Eurovet Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eurovet Recent Developments/Updates
2.4 Hipra
2.4.1 Hipra Details
2.4.2 Hipra Major Business
2.4.3 Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
2.4.4 Hipra Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hipra Recent Developments/Updates
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
2.5.4 Nisseiken Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nisseiken Recent Developments/Updates
2.6 Merck Animal Health
2.6.1 Merck Animal Health Details
2.6.2 Merck Animal Health Major Business
2.6.3 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
2.6.4 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Animal Health Recent Developments/Updates
2.7 SPAH
2.7.1 SPAH Details
2.7.2 SPAH Major Business
2.7.3 SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
2.7.4 SPAH Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 SPAH Recent Developments/Updates
2.8 Pulike Biological Engineering
2.8.1 Pulike Biological Engineering Details
2.8.2 Pulike Biological Engineering Major Business
2.8.3 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
2.8.4 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pulike Biological Engineering Recent Developments/Updates
2.9 China Animal Husbandry Industry
2.9.1 China Animal Husbandry Industry Details
2.9.2 China Animal Husbandry Industry Major Business
2.9.3 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
2.9.4 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 China Animal Husbandry Industry Recent Developments/Updates
2.10 Wuhan Keqian Biology
2.10.1 Wuhan Keqian Biology Details
2.10.2 Wuhan Keqian Biology Major Business
2.10.3 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
2.10.4 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Keqian Biology Recent Developments/Updates
2.11 Wo Hua Biotech
2.11.1 Wo Hua Biotech Details
2.11.2 Wo Hua Biotech Major Business
2.11.3 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.11.4 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wo Hua Biotech Recent Developments/Updates
2.12 Zhejiang Ceva Ebvac Biotech
2.12.1 Zhejiang Ceva Ebvac Biotech Details
2.12.2 Zhejiang Ceva Ebvac Biotech Major Business
2.12.3 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.12.4 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
2.13 Luoyang Huizhong Biotech
2.13.1 Luoyang Huizhong Biotech Details
2.13.2 Luoyang Huizhong Biotech Major Business
2.13.3 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.13.4 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Luoyang Huizhong Biotech Recent Developments/Updates
2.14 Beijing Centrebio Biology
2.14.1 Beijing Centrebio Biology Details
2.14.2 Beijing Centrebio Biology Major Business
2.14.3 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
2.14.4 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Beijing Centrebio Biology Recent Developments/Updates
2.15 Shandong Huahong Bioengineering
2.15.1 Shandong Huahong Bioengineering Details
2.15.2 Shandong Huahong Bioengineering Major Business
2.15.3 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
2.15.4 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shandong Huahong Bioengineering Recent Developments/Updates
2.16 Ringpu
2.16.1 Ringpu Details
2.16.2 Ringpu Major Business
2.16.3 Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
2.16.4 Ringpu Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ringpu Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HAEMOPHILUS PARASUIS BIVALENT VACCINE BY MANUFACTURER
3.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Haemophilus Parasuis Bivalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Haemophilus Parasuis Bivalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Haemophilus Parasuis Bivalent Vaccine Manufacturer Market Share in 2022
3.5 Haemophilus Parasuis Bivalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 Haemophilus Parasuis Bivalent Vaccine Market: Region Footprint
3.5.2 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
3.5.3 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Haemophilus Parasuis Bivalent Vaccine Market Size by Region
4.1.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2029)
4.2 North America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.3 Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.5 South America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Haemophilus Parasuis Bivalent Vaccine Market Size by Country
7.3.1 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Haemophilus Parasuis Bivalent Vaccine Market Size by Country
8.3.1 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Market Size by Region
9.3.1 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Haemophilus Parasuis Bivalent Vaccine Market Size by Country
10.3.1 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Market Size by Country
11.3.1 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Haemophilus Parasuis Bivalent Vaccine Market Drivers
12.2 Haemophilus Parasuis Bivalent Vaccine Market Restraints
12.3 Haemophilus Parasuis Bivalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Haemophilus Parasuis Bivalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Haemophilus Parasuis Bivalent Vaccine
13.3 Haemophilus Parasuis Bivalent Vaccine Production Process
13.4 Haemophilus Parasuis Bivalent Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Haemophilus Parasuis Bivalent Vaccine Typical Distributors
14.3 Haemophilus Parasuis Bivalent Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Haemophilus Parasuis Bivalent Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Bivalent Inactivated Vaccine
1.3.3 Trivalent Inactivated Vaccine
1.3.4 Quadrivalent Inactivated Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Haemophilus Parasuis Bivalent Vaccine Market Size & Forecast
1.5.1 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity (2018-2029)
1.5.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business
2.1.3 Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
2.1.4 Zoetis Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 Eurovet
2.3.1 Eurovet Details
2.3.2 Eurovet Major Business
2.3.3 Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
2.3.4 Eurovet Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Eurovet Recent Developments/Updates
2.4 Hipra
2.4.1 Hipra Details
2.4.2 Hipra Major Business
2.4.3 Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
2.4.4 Hipra Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Hipra Recent Developments/Updates
2.5 Nisseiken
2.5.1 Nisseiken Details
2.5.2 Nisseiken Major Business
2.5.3 Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
2.5.4 Nisseiken Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Nisseiken Recent Developments/Updates
2.6 Merck Animal Health
2.6.1 Merck Animal Health Details
2.6.2 Merck Animal Health Major Business
2.6.3 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
2.6.4 Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck Animal Health Recent Developments/Updates
2.7 SPAH
2.7.1 SPAH Details
2.7.2 SPAH Major Business
2.7.3 SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
2.7.4 SPAH Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 SPAH Recent Developments/Updates
2.8 Pulike Biological Engineering
2.8.1 Pulike Biological Engineering Details
2.8.2 Pulike Biological Engineering Major Business
2.8.3 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
2.8.4 Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Pulike Biological Engineering Recent Developments/Updates
2.9 China Animal Husbandry Industry
2.9.1 China Animal Husbandry Industry Details
2.9.2 China Animal Husbandry Industry Major Business
2.9.3 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
2.9.4 China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 China Animal Husbandry Industry Recent Developments/Updates
2.10 Wuhan Keqian Biology
2.10.1 Wuhan Keqian Biology Details
2.10.2 Wuhan Keqian Biology Major Business
2.10.3 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
2.10.4 Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Keqian Biology Recent Developments/Updates
2.11 Wo Hua Biotech
2.11.1 Wo Hua Biotech Details
2.11.2 Wo Hua Biotech Major Business
2.11.3 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.11.4 Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Wo Hua Biotech Recent Developments/Updates
2.12 Zhejiang Ceva Ebvac Biotech
2.12.1 Zhejiang Ceva Ebvac Biotech Details
2.12.2 Zhejiang Ceva Ebvac Biotech Major Business
2.12.3 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.12.4 Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
2.13 Luoyang Huizhong Biotech
2.13.1 Luoyang Huizhong Biotech Details
2.13.2 Luoyang Huizhong Biotech Major Business
2.13.3 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
2.13.4 Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Luoyang Huizhong Biotech Recent Developments/Updates
2.14 Beijing Centrebio Biology
2.14.1 Beijing Centrebio Biology Details
2.14.2 Beijing Centrebio Biology Major Business
2.14.3 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
2.14.4 Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Beijing Centrebio Biology Recent Developments/Updates
2.15 Shandong Huahong Bioengineering
2.15.1 Shandong Huahong Bioengineering Details
2.15.2 Shandong Huahong Bioengineering Major Business
2.15.3 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
2.15.4 Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Shandong Huahong Bioengineering Recent Developments/Updates
2.16 Ringpu
2.16.1 Ringpu Details
2.16.2 Ringpu Major Business
2.16.3 Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
2.16.4 Ringpu Haemophilus Parasuis Bivalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Ringpu Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HAEMOPHILUS PARASUIS BIVALENT VACCINE BY MANUFACTURER
3.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Haemophilus Parasuis Bivalent Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Haemophilus Parasuis Bivalent Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Haemophilus Parasuis Bivalent Vaccine Manufacturer Market Share in 2022
3.5 Haemophilus Parasuis Bivalent Vaccine Market: Overall Company Footprint Analysis
3.5.1 Haemophilus Parasuis Bivalent Vaccine Market: Region Footprint
3.5.2 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
3.5.3 Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Haemophilus Parasuis Bivalent Vaccine Market Size by Region
4.1.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2029)
4.2 North America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.3 Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.5 South America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2018-2029)
5.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2018-2029)
6.3 Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Haemophilus Parasuis Bivalent Vaccine Market Size by Country
7.3.1 North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Haemophilus Parasuis Bivalent Vaccine Market Size by Country
8.3.1 Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Market Size by Region
9.3.1 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Haemophilus Parasuis Bivalent Vaccine Market Size by Country
10.3.1 South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Market Size by Country
11.3.1 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Haemophilus Parasuis Bivalent Vaccine Market Drivers
12.2 Haemophilus Parasuis Bivalent Vaccine Market Restraints
12.3 Haemophilus Parasuis Bivalent Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Haemophilus Parasuis Bivalent Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Haemophilus Parasuis Bivalent Vaccine
13.3 Haemophilus Parasuis Bivalent Vaccine Production Process
13.4 Haemophilus Parasuis Bivalent Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Haemophilus Parasuis Bivalent Vaccine Typical Distributors
14.3 Haemophilus Parasuis Bivalent Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 6. Zoetis Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 11. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. Eurovet Basic Information, Manufacturing Base and Competitors
Table 14. Eurovet Major Business
Table 15. Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 16. Eurovet Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Eurovet Recent Developments/Updates
Table 18. Hipra Basic Information, Manufacturing Base and Competitors
Table 19. Hipra Major Business
Table 20. Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 21. Hipra Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hipra Recent Developments/Updates
Table 23. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 24. Nisseiken Major Business
Table 25. Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 26. Nisseiken Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nisseiken Recent Developments/Updates
Table 28. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Merck Animal Health Major Business
Table 30. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 31. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck Animal Health Recent Developments/Updates
Table 33. SPAH Basic Information, Manufacturing Base and Competitors
Table 34. SPAH Major Business
Table 35. SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 36. SPAH Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. SPAH Recent Developments/Updates
Table 38. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 39. Pulike Biological Engineering Major Business
Table 40. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 41. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pulike Biological Engineering Recent Developments/Updates
Table 43. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 44. China Animal Husbandry Industry Major Business
Table 45. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 46. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. China Animal Husbandry Industry Recent Developments/Updates
Table 48. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Keqian Biology Major Business
Table 50. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 51. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Keqian Biology Recent Developments/Updates
Table 53. Wo Hua Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Wo Hua Biotech Major Business
Table 55. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 56. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wo Hua Biotech Recent Developments/Updates
Table 58. Zhejiang Ceva Ebvac Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Ceva Ebvac Biotech Major Business
Table 60. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 61. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
Table 63. Luoyang Huizhong Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Luoyang Huizhong Biotech Major Business
Table 65. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 66. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Luoyang Huizhong Biotech Recent Developments/Updates
Table 68. Beijing Centrebio Biology Basic Information, Manufacturing Base and Competitors
Table 69. Beijing Centrebio Biology Major Business
Table 70. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 71. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Beijing Centrebio Biology Recent Developments/Updates
Table 73. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 74. Shandong Huahong Bioengineering Major Business
Table 75. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 76. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shandong Huahong Bioengineering Recent Developments/Updates
Table 78. Ringpu Basic Information, Manufacturing Base and Competitors
Table 79. Ringpu Major Business
Table 80. Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 81. Ringpu Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ringpu Recent Developments/Updates
Table 83. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 84. Global Haemophilus Parasuis Bivalent Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 86. Market Position of Manufacturers in Haemophilus Parasuis Bivalent Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Haemophilus Parasuis Bivalent Vaccine Production Site of Key Manufacturer
Table 88. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
Table 89. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
Table 90. Haemophilus Parasuis Bivalent Vaccine New Market Entrants and Barriers to Market Entry
Table 91. Haemophilus Parasuis Bivalent Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 93. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 94. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 97. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 98. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 99. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 100. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 103. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 104. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 105. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 106. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 109. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 110. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 111. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 112. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 113. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 114. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 115. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 116. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 119. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 120. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 121. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 122. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 123. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 124. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 127. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 128. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 129. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 130. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 131. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 132. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 135. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 136. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 137. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 138. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 139. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 140. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 143. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 144. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 145. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 146. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 147. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 148. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Haemophilus Parasuis Bivalent Vaccine Raw Material
Table 151. Key Manufacturers of Haemophilus Parasuis Bivalent Vaccine Raw Materials
Table 152. Haemophilus Parasuis Bivalent Vaccine Typical Distributors
Table 153. Haemophilus Parasuis Bivalent Vaccine Typical Customers
Table 1. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Major Business
Table 5. Zoetis Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 6. Zoetis Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 11. Boehringer-Ingelheim Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. Eurovet Basic Information, Manufacturing Base and Competitors
Table 14. Eurovet Major Business
Table 15. Eurovet Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 16. Eurovet Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Eurovet Recent Developments/Updates
Table 18. Hipra Basic Information, Manufacturing Base and Competitors
Table 19. Hipra Major Business
Table 20. Hipra Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 21. Hipra Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Hipra Recent Developments/Updates
Table 23. Nisseiken Basic Information, Manufacturing Base and Competitors
Table 24. Nisseiken Major Business
Table 25. Nisseiken Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 26. Nisseiken Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Nisseiken Recent Developments/Updates
Table 28. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 29. Merck Animal Health Major Business
Table 30. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 31. Merck Animal Health Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Merck Animal Health Recent Developments/Updates
Table 33. SPAH Basic Information, Manufacturing Base and Competitors
Table 34. SPAH Major Business
Table 35. SPAH Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 36. SPAH Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. SPAH Recent Developments/Updates
Table 38. Pulike Biological Engineering Basic Information, Manufacturing Base and Competitors
Table 39. Pulike Biological Engineering Major Business
Table 40. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 41. Pulike Biological Engineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Pulike Biological Engineering Recent Developments/Updates
Table 43. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 44. China Animal Husbandry Industry Major Business
Table 45. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 46. China Animal Husbandry Industry Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. China Animal Husbandry Industry Recent Developments/Updates
Table 48. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Keqian Biology Major Business
Table 50. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 51. Wuhan Keqian Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Keqian Biology Recent Developments/Updates
Table 53. Wo Hua Biotech Basic Information, Manufacturing Base and Competitors
Table 54. Wo Hua Biotech Major Business
Table 55. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 56. Wo Hua Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Wo Hua Biotech Recent Developments/Updates
Table 58. Zhejiang Ceva Ebvac Biotech Basic Information, Manufacturing Base and Competitors
Table 59. Zhejiang Ceva Ebvac Biotech Major Business
Table 60. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 61. Zhejiang Ceva Ebvac Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zhejiang Ceva Ebvac Biotech Recent Developments/Updates
Table 63. Luoyang Huizhong Biotech Basic Information, Manufacturing Base and Competitors
Table 64. Luoyang Huizhong Biotech Major Business
Table 65. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 66. Luoyang Huizhong Biotech Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Luoyang Huizhong Biotech Recent Developments/Updates
Table 68. Beijing Centrebio Biology Basic Information, Manufacturing Base and Competitors
Table 69. Beijing Centrebio Biology Major Business
Table 70. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 71. Beijing Centrebio Biology Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Beijing Centrebio Biology Recent Developments/Updates
Table 73. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 74. Shandong Huahong Bioengineering Major Business
Table 75. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 76. Shandong Huahong Bioengineering Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Shandong Huahong Bioengineering Recent Developments/Updates
Table 78. Ringpu Basic Information, Manufacturing Base and Competitors
Table 79. Ringpu Major Business
Table 80. Ringpu Haemophilus Parasuis Bivalent Vaccine Product and Services
Table 81. Ringpu Haemophilus Parasuis Bivalent Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Ringpu Recent Developments/Updates
Table 83. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 84. Global Haemophilus Parasuis Bivalent Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 86. Market Position of Manufacturers in Haemophilus Parasuis Bivalent Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Haemophilus Parasuis Bivalent Vaccine Production Site of Key Manufacturer
Table 88. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Type Footprint
Table 89. Haemophilus Parasuis Bivalent Vaccine Market: Company Product Application Footprint
Table 90. Haemophilus Parasuis Bivalent Vaccine New Market Entrants and Barriers to Market Entry
Table 91. Haemophilus Parasuis Bivalent Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 93. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 94. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 97. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 98. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 99. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 100. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 103. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 104. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 105. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 106. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 109. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 110. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 111. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 112. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 113. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 114. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 115. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 116. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 119. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 120. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 121. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 122. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 123. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 124. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 127. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 128. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 129. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 130. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 131. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 132. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 135. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 136. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 137. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 138. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 139. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 140. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 143. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 144. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 145. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 146. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 147. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 148. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Haemophilus Parasuis Bivalent Vaccine Raw Material
Table 151. Key Manufacturers of Haemophilus Parasuis Bivalent Vaccine Raw Materials
Table 152. Haemophilus Parasuis Bivalent Vaccine Typical Distributors
Table 153. Haemophilus Parasuis Bivalent Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Haemophilus Parasuis Bivalent Vaccine Picture
Figure 2. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Bivalent Inactivated Vaccine Examples
Figure 5. Trivalent Inactivated Vaccine Examples
Figure 6. Quadrivalent Inactivated Vaccine Examples
Figure 7. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Piglets Examples
Figure 10. Adults Pigs Examples
Figure 11. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 14. Global Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 15. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Haemophilus Parasuis Bivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Haemophilus Parasuis Bivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 30. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 33. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Haemophilus Parasuis Bivalent Vaccine Market Drivers
Figure 74. Haemophilus Parasuis Bivalent Vaccine Market Restraints
Figure 75. Haemophilus Parasuis Bivalent Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Haemophilus Parasuis Bivalent Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Haemophilus Parasuis Bivalent Vaccine
Figure 79. Haemophilus Parasuis Bivalent Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Haemophilus Parasuis Bivalent Vaccine Picture
Figure 2. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Bivalent Inactivated Vaccine Examples
Figure 5. Trivalent Inactivated Vaccine Examples
Figure 6. Quadrivalent Inactivated Vaccine Examples
Figure 7. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Piglets Examples
Figure 10. Adults Pigs Examples
Figure 11. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 14. Global Haemophilus Parasuis Bivalent Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 15. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Haemophilus Parasuis Bivalent Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Haemophilus Parasuis Bivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Haemophilus Parasuis Bivalent Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 30. Global Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Haemophilus Parasuis Bivalent Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 33. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Haemophilus Parasuis Bivalent Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Haemophilus Parasuis Bivalent Vaccine Market Drivers
Figure 74. Haemophilus Parasuis Bivalent Vaccine Market Restraints
Figure 75. Haemophilus Parasuis Bivalent Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Haemophilus Parasuis Bivalent Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Haemophilus Parasuis Bivalent Vaccine
Figure 79. Haemophilus Parasuis Bivalent Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
